These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5889350)

  • 1. [Triamcinolone in the prevention of secondary reactions to hetrazan].
    Berhard JA; Figueroa LN; García Manzo GA
    Salud Publica Mex; 1964; 6(5):835-41. PubMed ID: 5889350
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of phosphate of betamethasone for the control of secondary reactions caused by Hetrazan in patients with onchocerciasis].
    Garcia Manzo A; Figueroa LN; Bernhard JA
    Salud Publica Mex; 1965; 7(2):209-12. PubMed ID: 5889406
    [No Abstract]   [Full Text] [Related]  

  • 3. [TRIAMCINOLONE AS A PROPHYLACTIC IN THE SECONDARY REACTIONS PRODUCED BY HETRAZAN].
    FIGUEROA LN; GARCIAMANZO GA; BERNHARD JA
    Rev Col Med Guatem; 1963 Dec; 14():140-8. PubMed ID: 14125653
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions to cutaneous diethylcarbamazine in onchocerciasis.
    Hutchinson DB; El-Sheikh H; Jones BR; Anderson J; Fuglsang H; Mackenzie CD
    Lancet; 1979 Jul; 2(8132):46. PubMed ID: 87926
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study to evaluate the prevention of therapeutic shock in onchocerciasis].
    Villamayor CA
    Salud Publica Mex; 1970; 12(3):321-31. PubMed ID: 5516723
    [No Abstract]   [Full Text] [Related]  

  • 6. Leprosy, onchocerciasis, diethylcarbamazine and the Mazzotti reaction.
    Stingl P; Stingl M
    Lepr Rev; 1982 Dec; 53(4):317-8. PubMed ID: 7154815
    [No Abstract]   [Full Text] [Related]  

  • 7. Need for caution in use of DEC for treatment of onchocerciasis.
    Duke BO; Thylefors B
    Trop Doct; 1986 Apr; 16(2):69-70. PubMed ID: 3765081
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatalities after treatment of onchocerciasis with diethylcarbamazine.
    Oomen AP
    Trans R Soc Trop Med Hyg; 1969; 63(4):548. PubMed ID: 5821282
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and histological evaluation of the treatment of a clinical case of onchocerciasis with antrypol and hetrazan].
    Prix R; Jindrák K
    Med Welt; 1967 Oct; 42():2502-6. PubMed ID: 5615283
    [No Abstract]   [Full Text] [Related]  

  • 10. DEC treatment of onchocerciasis.
    Plaut GS
    Trop Doct; 1988 Apr; 18(2):94. PubMed ID: 3368961
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteinuria associated with diethylcarbamazine treatment of onchocerciasis.
    Greene BM; Taylor HR; Humphrey RL
    Lancet; 1980 Feb; 1(8162):254-5. PubMed ID: 6101700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological status of onchocerciasis patients and its changes during diethylcarbamazine and suramin treatment (a review of the literature)].
    Ovusu A
    Med Parazitol (Mosk); 1983; (5):81-7. PubMed ID: 6358827
    [No Abstract]   [Full Text] [Related]  

  • 13. [RESULTS OF FIELD TRIALS OF DIETHYLCARBAMAZINE ASSOCIATED WITH METHDILAZINE HYDROCHLORIDE AND TRIAMCINOLONE; STATISTICS ON THE COMPARATIVELY UNFAVORABLE REACTIONS OF THE USE OF DIETHYLCARBAMAZINE ALONE].
    TORROELLA J
    Salud Publica Mex; 1964; 6():595-7. PubMed ID: 14196475
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Collapse during treatment of onchocerciasis with diethylcarbamazine.
    Fuglsang H; Anderson J
    Trans R Soc Trop Med Hyg; 1974; 68(1):72-3. PubMed ID: 4818668
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual loss during oral diethylcarbamazine treatment for onchocerciasis.
    Bird AC; El-Sheikh H; Anderson J; Fuglsang H
    Lancet; 1979 Jul; 2(8132):46. PubMed ID: 87927
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development of onchocercosis in a patient outside the transmission zone treated with Hetrazan].
    González Barranco D; Salazar Mallén M
    Rev Invest Salud Publica; 1968; 28(4):309-12. PubMed ID: 5735892
    [No Abstract]   [Full Text] [Related]  

  • 17. Deseril and diethylcarbamazine in the treatment of onchocerciasis.
    Fuglsang H; Anderson J
    Trans R Soc Trop Med Hyg; 1976; 70(5-6):534. PubMed ID: 841663
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of onchocerciasis: a controlled clinical trial of topical diethylcarbamazine (DEC) in Guatemala.
    Taylor HR; Langham ME; de Stahl EM; Figueroa LN; Beltranena F
    Tropenmed Parasitol; 1980 Sep; 31(3):357-64. PubMed ID: 7003855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comments upon onchocerciasis (author's transl)].
    Vedy J; Graveline J; Cahuzac G
    Med Trop (Mars); 1981; 41(5):503-4. PubMed ID: 7321841
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on Bancroftian filariasis in Liberia, West Africa. IV. Notes on side effects observed during a diethylcarbamazine treatment campaign in a rural area endemic for Wuchereria bancrofti and Onchocerca volvulus.
    Chlebowsky HO; Zielke E
    Tropenmed Parasitol; 1980 Sep; 31(3):339-44. PubMed ID: 7003853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.